FDA Requires Transvaginal Mesh Makers To Conduct Safety Studies

Bernstein Liebhard LLP endorses an FDA mandate requiring transvaginal mesh manufacturers to initiate investigations into implant related injuries. New York, New York (PRWEB) January 04, 2012 Bernstein Liebhard LLP reports that on January 3, 2012, the U.S. Food and Drug Administration (“FDA”) ordered Johnson & Johnson and C.R. Bard Inc., manufacturers of vaginal mesh implants, to study rates of side effects such as organ damage, infection and painful sexual intercourse, which have been linked to the transvaginal mesh implants.* In addition to Johnson & Johnson and C.R. Bard, 31 oth
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations